Title:Micronutrient Deficiency in Pulmonary Tuberculosis - Perspective on Hepatic
Drug Metabolism and Pharmacokinetic Variability of First-line Anti-
Tuberculosis Drugs: Special Reference to Fat-soluble Vitamins A, D, & E
and Nutri-epigenetics
Volume: 14
Issue: 3
Author(s): Jeyakumar Shanmugam Murugaiha*
Affiliation:
- Department of Clinical Pharmacology, ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT), Chennai,
600031, Tamil Nadu, India
Keywords:
Cytochrome, liver, retinol, epigenetic, gene, enzyme, xenobiotic.
Abstract: Abstract: The liver plays a crucial role in endogenous metabolic activity and homeostasis of
macro and micronutrients. Further, it acts as a metabolic hub in mammals, where the ingested
food-derived nutrients and xenobiotics or drugs are metabolized for utilization and/or excretion
through its enzymatic and non-enzymatic machinery. Nutritional deficiency, one of the major
public health problems, is associated with global disease burden, including pulmonary tuberculosis
(PTB) caused by Mycobacterium tuberculosis (Mtb) infection. Though it is a curable and preventable
infectious disease, millions of people succumb to death, and people in numbers larger
than this are still suffering. This scenario is further complicated by the addition of new cases, disease
recurrence, and the emergence of drug-resistant, all of which contribute to the spread of this
epidemic. Though the manifestation of TB disease has multiple aetiologies, poor nutritional status
and sub-optimal therapeutic concentrations of first-line anti-TB drugs are considered as potential
contributors to its widespread prevalence. Among various factors, the pharmacokinetic variability
of anti-TB drugs is one of the main causes for sub-optimal therapeutic drug concentration in TB patients,
which is influenced by the host’s genetic make-up and nutritional status, besides several
others. However, the role of epigenetic changes in hepatic drug metabolic pathways and their transcript
levels is largely unexplored. Therefore, in this review, an attempt has been made to understand
the role of micronutrient deficiencies with special reference to fat-soluble vitamins, namely vitamin
A, D, & E in pulmonary TB, their possible impact on epigenetic changes on the drug-metabolizing
pathway genes, thus their expression levels and plausible influence on pharmacokinetic variability
of anti-TB drugs, besides discussing the limitations and emerging potential opportunities.
Eventually, this would help in developing the host-directed/personalized therapeutic strategies for
the elimination of pulmonary tuberculosis (PTB).